Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prospectively compare the physiologic response of patients
who receive either intravenous gadoxetic acid (Eovist) or intravenous gadobenate dimeglumine
(MultiHance).